CD80 and focal segmental glomerulosclerosis: Most recently, it was reported that no significant up-regulation of podocyte CD80 was detected in MCD and FSGS patients' biopsies compared with controls using different primary antibodies and immunohistochemical assays, suggesting further confirmation is needed with CD80 in MCD52.